Literature DB >> 24186077

Assessment of reinforcement enhancing effects of toluene vapor and nitrous oxide in intracranial self-stimulation.

Matthew E Tracy1, Galina G Slavova-Hernandez, Keith L Shelton.   

Abstract

RATIONALE: Despite widespread abuse, there are few validated methods to study the rewarding effects of inhalants. One model that may have utility for this purpose is intracranial self-stimulation (ICSS).
OBJECTIVES: This study aims to compare and contrast the ICSS reward-facilitating effects of abused inhalants to other classes of abused drugs. Compounds were examined using two different ICSS procedures in mice to determine the generality of each drug's effects on ICSS and the sensitivity of the procedures.
METHODS: Male C57BL/6J mice with electrodes implanted in the medial forebrain bundle were trained under a three-component rate-frequency as well as a progressive ratio (PR) ICSS procedure. The effects of nitrous oxide, toluene vapor, cocaine, and diazepam on ICSS were then examined.
RESULTS: Concentrations of 1,360-2,900 parts per million (ppm) inhaled toluene vapor significantly facilitated ICSS in the rate-frequency procedure and 1,360 ppm increased PR breakpoint. A concentration of 40 % nitrous oxide facilitated ICSS in the rate-frequency procedure but reduced PR breakpoint. Doses of 3-18 mg/kg cocaine facilitated ICSS in the rate-frequency procedure, and 10 and 18 mg/kg increased PR breakpoint. Doses of 1 and 3 mg/kg diazepam facilitated ICSS in the rate-frequency procedure, and 3 mg/kg increased PR breakpoint.
CONCLUSIONS: The reinforcement-facilitating effect of toluene in ICSS is at least as great as diazepam. By contrast, nitrous oxide weakly enhances ICSS in only the rate-frequency procedure. The data suggest that the rate-frequency procedure may be more sensitive than the PR schedule to the reward-facilitating effects of abused inhalants.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24186077      PMCID: PMC3954938          DOI: 10.1007/s00213-013-3327-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  54 in total

Review 1.  Clinical review of inhalants.

Authors:  T Brouette; R Anton
Journal:  Am J Addict       Date:  2001

2.  Nitrous oxide and xenon increase the efficacy of GABA at recombinant mammalian GABA(A) receptors.

Authors:  G Hapfelmeier; W Zieglgänsberger; R Haseneder; H Schneck; E Kochs
Journal:  Anesth Analg       Date:  2000-12       Impact factor: 5.108

3.  Distribution of c-Fos immunoreactivity in the rat brain following abuse-like toluene vapor inhalation.

Authors:  Kristina E Perit; Jimmie M Gmaz; J D Caleb Browne; Brittany A Matthews; Mary Beth F Dunn; Linda Yang; Tanya Raaphorst; Paul E Mallet; Bruce E McKay
Journal:  Neurotoxicol Teratol       Date:  2011-10-30       Impact factor: 3.763

Review 4.  Subacute combined degeneration caused by nitrous oxide intoxication: case reports.

Authors:  Ru-Jen Lin; Hoi-Fong Chen; Yang-Chyuan Chang; Jen-Jen Su
Journal:  Acta Neurol Taiwan       Date:  2011-06

5.  Within- and between-subject variability in the reinforcing and subjective effects of nitrous oxide in healthy volunteers.

Authors:  D J Walker; J P Zacny
Journal:  Drug Alcohol Depend       Date:  2001-09-01       Impact factor: 4.492

6.  Some determinants of morphine effects on intracranial self-stimulation in rats: dose, pretreatment time, repeated treatment, and rate dependence.

Authors:  Ahmad A Altarifi; Sidney Stevens Negus
Journal:  Behav Pharmacol       Date:  2011-10       Impact factor: 2.293

7.  Bitonic dose-response functions for reinforcing and self-reported effects of nitrous oxide in humans.

Authors:  Diana J Walker; James P Zacny
Journal:  Pharmacol Biochem Behav       Date:  2003-03       Impact factor: 3.533

8.  Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward.

Authors:  Lauren M Reynolds; Elif Engin; Gabriella Tantillo; Hew Mun Lau; John W Muschamp; William A Carlezon; Uwe Rudolph
Journal:  Neuropsychopharmacology       Date:  2012-07-04       Impact factor: 7.853

9.  Conditioned place aversion and self-administration of nitrous oxide in rats.

Authors:  Douglas S Ramsay; Chae H Watson; Brian G Leroux; Christopher W Prall; Karl J Kaiyala
Journal:  Pharmacol Biochem Behav       Date:  2003-02       Impact factor: 3.533

10.  Progressive-ratio responding for palatable high-fat and high-sugar food in mice.

Authors:  Sandeep Sharma; Cecile Hryhorczuk; Stephanie Fulton
Journal:  J Vis Exp       Date:  2012-05-03       Impact factor: 1.355

View more
  6 in total

1.  Review of toluene action: clinical evidence, animal studies and molecular targets.

Authors:  Silvia L Cruz; María Teresa Rivera-García; John J Woodward
Journal:  J Drug Alcohol Res       Date:  2014

2.  The group II metabotropic glutamate receptor agonist LY379268 reduces toluene-induced enhancement of brain-stimulation reward and behavioral disturbances.

Authors:  Ming-Huan Chan; Yi-Ling Tsai; Mei-Yi Lee; Astrid K Stoker; Athina Markou; Hwei-Hsien Chen
Journal:  Psychopharmacology (Berl)       Date:  2015-06-06       Impact factor: 4.530

Review 3.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

4.  Abuse-related effects of subtype-selective GABAA receptor positive allosteric modulators in an assay of intracranial self-stimulation in rats.

Authors:  Kathryn L Schwienteck; Guanguan Li; Michael M Poe; James M Cook; Matthew L Banks; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2017-04-01       Impact factor: 4.530

5.  Negative allosteric modulation of GABAA receptors inhibits facilitation of brain stimulation reward by drugs of abuse in C57BL6/J mice.

Authors:  Matthew E Tracy; Matthew L Banks; Keith L Shelton
Journal:  Psychopharmacology (Berl)       Date:  2015-11-27       Impact factor: 4.530

6.  The Effects of Drugs on Behavior Maintained by Social Contact: Role of Monoamines in Social Reinforcement.

Authors:  Jessica L Sharp; Mark A Smith
Journal:  Front Behav Neurosci       Date:  2022-02-21       Impact factor: 3.617

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.